Last reviewed · How we verify
NCT04652063
Osteopathic Manipulative Medicine to Reduce Developmental Delays
NA trial testing Osteopathic Manipulative Medicine in Extreme Prematurity in 150 participants. Completed in 30 July 2023.
1 December 2022
Quick facts
| Lead sponsor | University of Rochester |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | prevention |
| Enrollment | 150 |
| Start date | 5 January 2021 |
| Primary completion | 1 December 2022 |
| Estimated completion | 30 July 2023 |
| Sites | 2 locations across United States |
Drugs / interventions tested
- Osteopathic Manipulative Medicine
Conditions studied
- Extreme Prematurity — all drugs for Extreme Prematurity →
- Neurodevelopmental Abnormality — all drugs for Neurodevelopmental Abnormality →
Sponsor
University of Rochester
Who can join
Adults 1 Day to 14 Weeks, any sex, with Extreme Prematurity or Neurodevelopmental Abnormality. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This randomized clinical trial seeks to determine if osteopathic manipulative medicine (OMM) increases the likelihood of improved neurodevelopmental outcomes as estimated by the Test of Infant Motor Performance (TIMP).
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04652063
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Osteopathic Manipulative Medicine
Trials testing the same drug.
- NCT06125574 — Investigating the Effects of Osteopathic Manipulative Treatment on Stress Management in Medical Students · NA · completed
- NCT04975542 — Efficacy of Osteopathic Manipulation on Breathing Mechanics in a Healthy Population: A Randomized Controlled Study · NA · completed
- NCT04764877 — Effect of Osteopathic Manipulation Therapy on Pulmonary Function Testing in Children With Asthma · NA · completed
Other recruiting trials for Extreme Prematurity
Currently open trials in the same condition.
- NCT06512935 — Ventilator Pressure and Optimization of Compliance and Hemodynamics · NA · recruiting
- NCT05347238 — Dopamine vs. Norepinephrine for Hypotension in Very Preterm Infants With Late-onset Sepsis · recruiting
- NCT04413097 — Delayed Cord Clamping With Oxygen In Extremely Low Gestation Infants · NA · active not recruiting
- NCT06027645 — Early Intervention Based on Neonatal Crawling in Very Premature Infants at Risk For Neurodevelopmental Disorder · NA · recruiting
- NCT03997266 — NICU Antibiotics and Outcomes Trial · Phase 4 · active not recruiting
Other University of Rochester trials
Trials by the same sponsor.
- NCT07075965 — Calcium Channel Blocker in Myotonic Dystrophy Type 1 · Phase 1 · not yet recruiting
- NCT07423104 — A Study of Cladribine, Low Dose Cytarabine, and Venetoclax in Treatment of Relapsed/Refractory or Secondary Acute Myeloi · Phase 2 · not yet recruiting
- NCT05744869 — SBAT for Health Equity · NA · not yet recruiting
- NCT06052956 — Efficacy of Methylene Blue Photodynamic Therapy for Treatment of Deep Tissue Abscesses · Phase 2 · not yet recruiting
- NCT07032636 — Reducing Crises and Suicide Within the Idaho Army National Guard · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04652063 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Rochester
- Last refreshed: 14 August 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04652063.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing